Moderna (MRNA)
(Delayed Data from NSDQ)
$140.03 USD
-5.20 (-3.58%)
Updated Jun 14, 2024 04:00 PM ET
After-Market: $139.64 -0.39 (-0.28%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Brokerage Reports
Moderna, Inc. [MRNA]
Reports for Purchase
Showing records 221 - 240 ( 256 total )
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Coronavirus Note, Vol.3: Testing Grows as More Diagnostics Come Online
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Yas'' Weekly Recap of Our Key Notes and 19 Doc Calls Upcoming in 1H20
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Takeaways from Our Deep Dive mRNA Vaccine Call with Mgmt
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Coronavirus Crisis Update- Infections Moving West
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Yas'' Weekly Recap of Our Key Notes and 8 Doc Calls Upcoming in 1H20
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
4Q19 - Prophylactics Are the Golden Ticket Going Forward for MRNA
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Dial in Friday to Hear Why MRNA''s Prophylactic Vaccines Are the Chosen Few
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Dial-in to Our Call on Why MRNA''s Prophylactic Vaccines Are the Chosen Few
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Yas'' Weekly Recap of Our Key Notes and 12 Doc Calls Upcoming in 1H20
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
mRNA Vaccines Teach Old Dog a New Trick for Coronavirus
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Healthcare - Yas'' Weekly Recap of Our Key Notes and 9 Doc Calls Upcoming in 1Q20
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y